All Posts:News Release
-
Early Study Results Suggest Fertility App as Effective as Modern Family Planning Methods
MEDIA CONTACTKaren Teberkm463@georgetown.edu WASHINGTON (October 15, 2018) — Early results from a first-of-its-kind study suggest that typical use of a family planning app called Dot is as effective as other modern methods for avoiding an unplanned pregnancy. Researchers from the Institute for Reproductive Health (IRH) at Georgetown University Medical Center are studying women’s use of […]
Category: News Release
-
More Clues Revealed in Link Between Normal Breast Changes and Invasive Breast Cancer
A research team led by investigators from Georgetown Lombardi Comprehensive Cancer Center has published the results of a mouse study that shows how changes in mammary glands to accommodate breastfeeding use a molecular process believed to contribute to the survival of premalignant breast cells.
Category: News Release
-
Nobel Prize-winning Science is Key to New Treatments for Cancer
The science that earned two researchers the Nobel Prize in Physiology or Medicine for 2018 — the discovery of cancer therapy by inhibition of negative immune regulation — is at the heart of an increasing number of standard treatments and many ongoing clinical trials at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Mouse Study Mirrors Human Findings That Link Chemotherapy and APOE4 to Cognitive Issues
New research by Georgetown University Medical Center investigators indicates that a chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, which is known to significantly increase the risk of developing Alzheimer’s disease.
Category: News Release
-
First Large Study Details Cognitive Outcomes Among Older Breast Cancer Patients
The first large U.S. study of cognition in older breast cancer patients, led by researchers from Georgetown Lombardi Comprehensive Cancer Center, indicates that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.
Category: News Release
-
Animal Study Suggests Deep Space Travel May Significantly Damage GI Function in Astronauts
Simulations with animal models meant to mirror galactic cosmic radiation exposure to astronauts are raising red flags for investigators at Georgetown University Medical Center about the health of astronauts during long voyages, such as to Mars.
Category: News Release
-
Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown
Georgetown University Medical Center announces a clinical trial testing the safety of the repurposed cancer drug nilotinib in Huntington’s disease. This is the fourth clinical trial of the drug for a neurodegenerative disorder.
Category: News Release
-
Use of Electrical Brain Stimulation to Foster Creativity Has Sweeping Implications
What is creativity, and can it be enhanced — safely — in a person who needs a boost of imagination? In a newly published article, Georgetown experts debate the growing use of electrical devices that stimulate brain tissue to improve various forms of creative cognition.
Category: News Release
-
Georgetown University Medical Center Names Subha Madhavan As Chief Data Scientist
Georgetown University Medical Center has named Subha Madhavan, PhD, as its Chief Data Scientist and director of its newly established Office for Health Data Science and Informatics.
Category: News Release
-
Probiotic Use May Reduce Antibiotic Prescriptions, Researchers Say
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics published by an international team that included Daniel Merenstein, MD, a professor in the Department of Family Medicine at Georgetown University School of Medicine.
Category: News Release